From: A novel strategy to identify candidate diagnostic and prognostic biomarkers for gastric cancer
Variables | Univariate analyses | Multivariate analyses | ||
---|---|---|---|---|
HR (95% CI) | P-value | HR (95% CI) | P-value | |
GSE15459 | ||||
Three gene risk score | 2.470 (1.620–3.767) | < 0.001 | 1.806 (1.178–2.771) | 0.007 |
Gender | 0.713 (0.462–1.101) | 0.127 | ||
Age | 0.966 (0.645–1.445) | 0.865 | ||
Stage | 6.520 (3.597–11.816) | < 0.001 | 5.684 (3.110–10.389) | < 0.001 |
TCGA | ||||
Three gene risk score | 1.446 (1.034–2.022) | 0.031 | 1.296 (0.918–1.829) | 0.141 |
Gender | 0.917 (0.644–1.306) | 0.630 | ||
Age | 0.933 (0.669–1.301) | 0.682 | ||
Tumor invasion | 1.880 (1.218–2.902) | 0.004 | 2.218 (1.405–3.500) | 0.001 |
Lymph node invasion | 1.727 (1.145–2.605) | 0.009 | 1.482 (0.884–2.485) | 0.135 |
Metastasis | 1.931 (1.067–3.496) | 0.030 | 1.893 (1.021–3.508) | 0.043 |
Pathological stage | 1.518 (1.082–2.128) | 0.016 | 1.196 (0.768–1.861) | 0.428 |
Histological grade | 1.313 (0.924–1.866) | 0.129 |